Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia

doi:10.1038/leu.2015.236

. 2016 Apr;30(4):999-1002.

doi: 10.1038/leu.2015.236. Epub 2015 Aug 28.

Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia

I Antony-Debré^{1

2}, N Duployez^{3

4}, M Bucci³, S Geffroy^{3

4}, J-B Micol^{2

5

6}, A Renneville^{3

4}, N Boissel⁷, N Dhédin⁷, D Réa⁷, B Nelken⁸, C Berthon^{4

9}, T Leblanc¹⁰, M-J Mozziconacci¹¹, R Favier^{2

12}, P G Heller¹³, O Abdel-Wahab⁵, H Raslova², V Latger-Cannard¹⁴, C Preudhomme^{3

4}

Affiliations

¹ Department of Cell Biology, Albert Einstein College of Medicine, New York, NY, USA.
² INSERM UMR1170, Institut Gustave Roussy, University Paris-Sud 11, Equipe labellisée Ligue Contre le Cancer, Villejuif, France.
³ Laboratory of Hematology, University Lille Nord de France, Lille, France.
⁴ INSERM UMR-S 1172, Lille, France.
⁵ Human Oncology and Pathogenesis Program and Leukemia Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
⁶ Department of Hematology, Institut Gustave Roussy, Villejuif, France.
⁷ Department of Hematology, Hôpital Saint-Louis, University Paris Diderot, Paris, France.
⁸ Department of Pediatric Hematology, CHU of Lille, Lille, France.
⁹ Department of Hematology, CHU of Lille, Lille, France.
¹⁰ Department of Pediatric Hematology, Hôpital Robert Debré, Paris, France.
¹¹ Department of Molecular Biology and Cytogenetics, Institut Paoli-Calmettes, Marseille, France.
¹² Laboratory of Hematology, Hôpital Trousseau, Paris, France.
¹³ Department of Hematology Research, Instituto de Investigaciones Médicas Alfredo Lanari, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cientificas y Technicas, Buenos Aires, Argentina.
¹⁴ Laboratory of Hematology, Nancy University Hospital, Nancy, France.

PMID: 26316320
DOI: 10.1038/leu.2015.236

Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia

I Antony-Debré et al. Leukemia. 2016 Apr.

. 2016 Apr;30(4):999-1002.

doi: 10.1038/leu.2015.236. Epub 2015 Aug 28.

Authors

Affiliations

¹ Department of Cell Biology, Albert Einstein College of Medicine, New York, NY, USA.
² INSERM UMR1170, Institut Gustave Roussy, University Paris-Sud 11, Equipe labellisée Ligue Contre le Cancer, Villejuif, France.
³ Laboratory of Hematology, University Lille Nord de France, Lille, France.
⁴ INSERM UMR-S 1172, Lille, France.
⁵ Human Oncology and Pathogenesis Program and Leukemia Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.
⁶ Department of Hematology, Institut Gustave Roussy, Villejuif, France.
⁷ Department of Hematology, Hôpital Saint-Louis, University Paris Diderot, Paris, France.
⁸ Department of Pediatric Hematology, CHU of Lille, Lille, France.
⁹ Department of Hematology, CHU of Lille, Lille, France.
¹⁰ Department of Pediatric Hematology, Hôpital Robert Debré, Paris, France.
¹¹ Department of Molecular Biology and Cytogenetics, Institut Paoli-Calmettes, Marseille, France.
¹² Laboratory of Hematology, Hôpital Trousseau, Paris, France.
¹³ Department of Hematology Research, Instituto de Investigaciones Médicas Alfredo Lanari, Universidad de Buenos Aires, Consejo Nacional de Investigaciones Cientificas y Technicas, Buenos Aires, Argentina.
¹⁴ Laboratory of Hematology, Nancy University Hospital, Nancy, France.

PMID: 26316320
DOI: 10.1038/leu.2015.236

No abstract available

PubMed Disclaimer

Cited by

Genetic Predisposition to Hematologic Malignancies in Childhood and Adolescence.
Fabozzi F, Mastronuzzi A. Fabozzi F, et al. Mediterr J Hematol Infect Dis. 2023 May 1;15(1):e2023032. doi: 10.4084/MJHID.2023.032. eCollection 2023. Mediterr J Hematol Infect Dis. 2023. PMID: 37180200 Free PMC article. Review.
A Systematic Review of the Role of Runt-Related Transcription Factor 1 (RUNX1) in the Pathogenesis of Hematological Malignancies in Patients With Inherited Bone Marrow Failure Syndromes.
Illango J, Sreekantan Nair A, Gor R, Wijeratne Fernando R, Malik M, Siddiqui NA, Hamid P. Illango J, et al. Cureus. 2022 May 26;14(5):e25372. doi: 10.7759/cureus.25372. eCollection 2022 May. Cureus. 2022. PMID: 35765406 Free PMC article. Review.
Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0.
Manchev VT, Bouzid H, Antony-Debré I, Leite B, Meurice G, Droin N, Prebet T, Costello RT, Vainchenker W, Plo I, Diop M, Macintyre E, Asnafi V, Favier R, Baccini V, Raslova H. Manchev VT, et al. J Cell Mol Med. 2017 Jun;21(6):1237-1242. doi: 10.1111/jcmm.13051. Epub 2016 Dec 20. J Cell Mol Med. 2017. PMID: 27997762 Free PMC article.
Clonal evolution in inherited marrow failure syndromes predicts disease progression.
Schratz KE. Schratz KE. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):125-134. doi: 10.1182/hematology.2023000469. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066914 Free PMC article. Review.
Zebrafish Cancer Predisposition Models.
Kobar K, Collett K, Prykhozhij SV, Berman JN. Kobar K, et al. Front Cell Dev Biol. 2021 Apr 27;9:660069. doi: 10.3389/fcell.2021.660069. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33987182 Free PMC article. Review.

See all "Cited by" articles

References

1. Nat Commun. 2014 Aug 27;5:4770 - PubMed
1. Blood. 2011 Dec 8;118(24):6310-20 - PubMed
1. J Clin Oncol. 2011 Apr 1;29(10):1364-72 - PubMed
1. Leukemia. 2006 Jun;20(6):965-70 - PubMed
1. Blood. 2015 Feb 5;125(6):930-40 - PubMed

Publication types

Actions
Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

Grants and funding

1K08CA160647-01/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

[1] Nat Commun. 2014 Aug 27;5:4770 - PubMed

[2] Nat Commun. 2014 Aug 27;5:4770 - PubMed

[3] Blood. 2011 Dec 8;118(24):6310-20 - PubMed

[4] Blood. 2011 Dec 8;118(24):6310-20 - PubMed

[5] J Clin Oncol. 2011 Apr 1;29(10):1364-72 - PubMed

[6] J Clin Oncol. 2011 Apr 1;29(10):1364-72 - PubMed

[7] Leukemia. 2006 Jun;20(6):965-70 - PubMed

[8] Leukemia. 2006 Jun;20(6):965-70 - PubMed

[9] Blood. 2015 Feb 5;125(6):930-40 - PubMed

[10] Blood. 2015 Feb 5;125(6):930-40 - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia

Affiliations

Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia

Authors

Affiliations

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Medical